4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
European Gram Negative Antibacterial Engine (ENABLE)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2020,
The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens. There is a growing concern that the loss of therapeutic options will present us with a post-antibiotic era where present and future medical advances are negated. Resistant bacteria dramatically reduce the possibilities of treating infections effectively, a ...
Voir le projet
42
Participants partenaires
TERMINÉ
Epigenetic regulation of economically important plant traits (EPITRAITS)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,
The mission of EpiTRAITS is to train young researchers in epigenetic gene regulation and flowering in the model plant Arabidopsis thaliana and the crop plants maize (Zea mays) and barley (Hordeum vulgare). Epigenetic gene regulation confers stability of gene expression patterns through cell divisions while allowing changes in expression in response to environmental or developmental cues. Although ...
Voir le projet
13
Participants partenaires
TERMINÉ
Developmental Origins of Healthy and Unhealthy Ageing: The Role of Maternal Obesity (DORIAN)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2014,
Europe has the highest proportion of elderly people in the world. Cardiovascular disease (CVD), type 2 diabetes (T2D), sarcopenia and cognitive decline frequently coexist in the same aged individual, sharing common early risk factors and being mutually reinforcing. Obesity is a main health concern in the world. In the EU one-third of women of reproductive age are overweight and 20% are obese, a pr ...
Voir le projet
10
Participants partenaires
TERMINÉ
Exploiting Gram-negative cell division targets in the test tube to obtain anti-microbial compounds (DIVINOCELL)
Date du début: 1 mars 2009, Date de fin: 31 août 2013,
The DIVINOCELL project will identify novel Gram-negative targets by exploiting the components of the divisome, their activities and interactions. It will also design selective assays for screening and will obtain a new class of antimicrobials: compounds to block bacterial division. New medicines to attack Gram-negative pathogens will decrease the burden of infectious disease and have a highly ben ...
Voir le projet